Concepts (319)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Hip | 77 | 2022 | 684 | 8.010 |
Why?
|
| Arthroplasty, Replacement, Knee | 54 | 2023 | 560 | 6.510 |
Why?
|
| Hip Prosthesis | 45 | 2022 | 436 | 5.160 |
Why?
|
| Prosthesis-Related Infections | 29 | 2023 | 177 | 4.940 |
Why?
|
| Prosthesis Failure | 39 | 2021 | 411 | 3.890 |
Why?
|
| Acetabulum | 17 | 2020 | 161 | 3.240 |
Why?
|
| Reoperation | 65 | 2023 | 743 | 2.980 |
Why?
|
| Knee Prosthesis | 21 | 2023 | 200 | 2.530 |
Why?
|
| Femur | 22 | 2019 | 298 | 2.510 |
Why?
|
| Prosthesis Design | 26 | 2022 | 382 | 2.390 |
Why?
|
| Arthritis, Infectious | 7 | 2023 | 47 | 1.770 |
Why?
|
| Knee Joint | 22 | 2022 | 572 | 1.700 |
Why?
|
| Aged | 75 | 2023 | 7638 | 1.640 |
Why?
|
| Humans | 129 | 2023 | 23156 | 1.600 |
Why?
|
| Osteolysis | 8 | 2015 | 113 | 1.430 |
Why?
|
| Middle Aged | 69 | 2022 | 7964 | 1.400 |
Why?
|
| Anti-Bacterial Agents | 9 | 2023 | 363 | 1.370 |
Why?
|
| Retrospective Studies | 48 | 2023 | 2989 | 1.340 |
Why?
|
| Male | 79 | 2022 | 12636 | 1.330 |
Why?
|
| Postoperative Complications | 17 | 2018 | 810 | 1.300 |
Why?
|
| Hip Joint | 14 | 2020 | 241 | 1.290 |
Why?
|
| Female | 76 | 2022 | 13117 | 1.270 |
Why?
|
| Bone Cements | 7 | 2020 | 78 | 1.250 |
Why?
|
| Joint Diseases | 6 | 2021 | 87 | 1.240 |
Why?
|
| Pain, Postoperative | 8 | 2022 | 272 | 1.220 |
Why?
|
| Aged, 80 and over | 46 | 2022 | 3857 | 1.120 |
Why?
|
| Radiography | 21 | 2019 | 521 | 0.960 |
Why?
|
| Periprosthetic Fractures | 6 | 2019 | 26 | 0.890 |
Why?
|
| Tibia | 10 | 2021 | 197 | 0.880 |
Why?
|
| Joint Instability | 8 | 2018 | 312 | 0.810 |
Why?
|
| Bone Resorption | 5 | 2014 | 75 | 0.800 |
Why?
|
| Hip Dislocation | 9 | 2016 | 48 | 0.790 |
Why?
|
| Vancomycin | 3 | 2018 | 51 | 0.780 |
Why?
|
| Treatment Outcome | 34 | 2023 | 2942 | 0.760 |
Why?
|
| Pelvic Bones | 3 | 2012 | 15 | 0.690 |
Why?
|
| Tobramycin | 2 | 2018 | 8 | 0.680 |
Why?
|
| Leg Length Inequality | 3 | 2016 | 9 | 0.670 |
Why?
|
| Gentamicins | 2 | 2018 | 22 | 0.670 |
Why?
|
| Synovial Fluid | 11 | 2017 | 82 | 0.660 |
Why?
|
| Tantalum | 8 | 2018 | 22 | 0.660 |
Why?
|
| Follow-Up Studies | 20 | 2019 | 1430 | 0.660 |
Why?
|
| Arthroplasty, Replacement | 2 | 2016 | 124 | 0.650 |
Why?
|
| Adult | 39 | 2022 | 6942 | 0.640 |
Why?
|
| Incidence | 9 | 2018 | 631 | 0.580 |
Why?
|
| Decision Support Techniques | 2 | 2011 | 39 | 0.570 |
Why?
|
| Radiostereometric Analysis | 1 | 2018 | 6 | 0.560 |
Why?
|
| Anti-Infective Agents, Local | 2 | 2016 | 46 | 0.560 |
Why?
|
| Osteotomy | 8 | 2014 | 123 | 0.550 |
Why?
|
| Population Surveillance | 2 | 2018 | 105 | 0.550 |
Why?
|
| Acute Kidney Injury | 1 | 2018 | 34 | 0.540 |
Why?
|
| Surgical Wound Infection | 2 | 2016 | 76 | 0.530 |
Why?
|
| Osseointegration | 7 | 2016 | 69 | 0.520 |
Why?
|
| Device Removal | 7 | 2013 | 68 | 0.520 |
Why?
|
| Mupirocin | 1 | 2016 | 17 | 0.490 |
Why?
|
| Bupivacaine | 1 | 2016 | 39 | 0.480 |
Why?
|
| Risk Factors | 12 | 2019 | 2019 | 0.480 |
Why?
|
| Anesthetics, Local | 1 | 2016 | 71 | 0.460 |
Why?
|
| Perioperative Care | 4 | 2017 | 42 | 0.460 |
Why?
|
| Metal-on-Metal Joint Prostheses | 2 | 2015 | 33 | 0.460 |
Why?
|
| Osteoarthritis, Hip | 4 | 2015 | 81 | 0.460 |
Why?
|
| Metals | 4 | 2015 | 96 | 0.450 |
Why?
|
| Femur Head | 2 | 2006 | 40 | 0.450 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2016 | 112 | 0.440 |
Why?
|
| Prospective Studies | 9 | 2019 | 1511 | 0.440 |
Why?
|
| Decision Trees | 2 | 2011 | 13 | 0.410 |
Why?
|
| Medical Device Recalls | 1 | 2013 | 1 | 0.410 |
Why?
|
| Osteoarthritis, Knee | 5 | 2021 | 299 | 0.400 |
Why?
|
| Dexamethasone | 1 | 2013 | 34 | 0.400 |
Why?
|
| Polymethyl Methacrylate | 2 | 2011 | 10 | 0.390 |
Why?
|
| Algorithms | 9 | 2022 | 304 | 0.390 |
Why?
|
| Bacteremia | 1 | 2013 | 98 | 0.380 |
Why?
|
| Coated Materials, Biocompatible | 3 | 2014 | 39 | 0.370 |
Why?
|
| Ketamine | 2 | 2022 | 23 | 0.370 |
Why?
|
| Fractures, Bone | 3 | 2013 | 70 | 0.370 |
Why?
|
| Patient Readmission | 1 | 2013 | 117 | 0.370 |
Why?
|
| Poisoning | 1 | 2012 | 1 | 0.370 |
Why?
|
| Antirheumatic Agents | 3 | 2017 | 83 | 0.370 |
Why?
|
| United States | 14 | 2022 | 1796 | 0.360 |
Why?
|
| Skin Diseases | 1 | 2012 | 21 | 0.360 |
Why?
|
| Prostheses and Implants | 2 | 2010 | 131 | 0.350 |
Why?
|
| Patient Satisfaction | 3 | 2019 | 257 | 0.340 |
Why?
|
| Transplantation, Homologous | 7 | 2015 | 198 | 0.340 |
Why?
|
| Biomechanical Phenomena | 8 | 2021 | 535 | 0.330 |
Why?
|
| Orthopedic Surgeons | 2 | 2022 | 24 | 0.320 |
Why?
|
| Demography | 3 | 2019 | 60 | 0.300 |
Why?
|
| Iliac Artery | 1 | 2009 | 5 | 0.300 |
Why?
|
| Quality of Life | 2 | 2011 | 564 | 0.300 |
Why?
|
| Foreign-Body Migration | 1 | 2009 | 18 | 0.300 |
Why?
|
| Bone Transplantation | 4 | 2012 | 155 | 0.290 |
Why?
|
| Recovery of Function | 8 | 2016 | 242 | 0.290 |
Why?
|
| Elective Surgical Procedures | 3 | 2018 | 32 | 0.290 |
Why?
|
| Time Factors | 10 | 2020 | 1264 | 0.280 |
Why?
|
| Rheumatology | 3 | 2017 | 77 | 0.270 |
Why?
|
| Patient Discharge | 1 | 2009 | 147 | 0.270 |
Why?
|
| Surgeons | 4 | 2022 | 77 | 0.270 |
Why?
|
| Arthroplasty | 3 | 2022 | 107 | 0.250 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2011 | 292 | 0.250 |
Why?
|
| Therapeutic Irrigation | 4 | 2019 | 44 | 0.250 |
Why?
|
| C-Reactive Protein | 7 | 2016 | 93 | 0.230 |
Why?
|
| Salmonella arizonae | 1 | 2005 | 1 | 0.220 |
Why?
|
| Cementation | 1 | 2005 | 30 | 0.220 |
Why?
|
| Occupational Diseases | 1 | 2005 | 21 | 0.220 |
Why?
|
| Risk Assessment | 8 | 2018 | 550 | 0.220 |
Why?
|
| Equipment Failure Analysis | 3 | 2015 | 79 | 0.220 |
Why?
|
| Cohort Studies | 7 | 2020 | 1463 | 0.210 |
Why?
|
| Physical Examination | 4 | 2019 | 87 | 0.210 |
Why?
|
| Debridement | 3 | 2013 | 66 | 0.210 |
Why?
|
| Feasibility Studies | 2 | 2018 | 210 | 0.200 |
Why?
|
| Clinical Competence | 2 | 2019 | 189 | 0.200 |
Why?
|
| Pain Measurement | 4 | 2016 | 412 | 0.190 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 2003 | 3 | 0.190 |
Why?
|
| Blood Sedimentation | 8 | 2016 | 49 | 0.190 |
Why?
|
| Preoperative Care | 5 | 2016 | 107 | 0.190 |
Why?
|
| Medicare | 4 | 2013 | 108 | 0.180 |
Why?
|
| Anesthesia, Conduction | 1 | 2022 | 30 | 0.180 |
Why?
|
| Biocompatible Materials | 3 | 2017 | 68 | 0.180 |
Why?
|
| Logistic Models | 3 | 2018 | 356 | 0.180 |
Why?
|
| Foreign Bodies | 1 | 2002 | 20 | 0.180 |
Why?
|
| Femoral Neck Fractures | 1 | 2022 | 9 | 0.180 |
Why?
|
| Case-Control Studies | 2 | 2018 | 485 | 0.180 |
Why?
|
| Postoperative Period | 3 | 2018 | 238 | 0.180 |
Why?
|
| Porosity | 5 | 2017 | 54 | 0.180 |
Why?
|
| Femoral Fractures | 2 | 2019 | 30 | 0.180 |
Why?
|
| Hemiarthroplasty | 1 | 2022 | 31 | 0.180 |
Why?
|
| Analgesics, Opioid | 2 | 2022 | 210 | 0.170 |
Why?
|
| Odds Ratio | 2 | 2019 | 227 | 0.170 |
Why?
|
| Leukocyte Count | 7 | 2016 | 58 | 0.170 |
Why?
|
| Bone Nails | 1 | 2020 | 12 | 0.160 |
Why?
|
| Arthrodesis | 1 | 2020 | 32 | 0.160 |
Why?
|
| Glucocorticoids | 2 | 2017 | 58 | 0.160 |
Why?
|
| Prescriptions | 1 | 2020 | 16 | 0.160 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2019 | 8 | 0.160 |
Why?
|
| Tertiary Care Centers | 1 | 2020 | 66 | 0.160 |
Why?
|
| Rheumatic Diseases | 2 | 2017 | 52 | 0.150 |
Why?
|
| Polyethylene | 2 | 2021 | 93 | 0.150 |
Why?
|
| Illinois | 2 | 2018 | 224 | 0.150 |
Why?
|
| Disease Management | 3 | 2017 | 98 | 0.150 |
Why?
|
| Treatment Failure | 1 | 2019 | 126 | 0.150 |
Why?
|
| Mobile Applications | 1 | 2019 | 27 | 0.150 |
Why?
|
| Physician Assistants | 1 | 2019 | 10 | 0.150 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 312 | 0.140 |
Why?
|
| Body Mass Index | 5 | 2020 | 381 | 0.140 |
Why?
|
| Nurse Practitioners | 1 | 2019 | 33 | 0.140 |
Why?
|
| Microspheres | 1 | 2018 | 24 | 0.140 |
Why?
|
| Range of Motion, Articular | 7 | 2020 | 564 | 0.140 |
Why?
|
| Creatinine | 1 | 2018 | 41 | 0.140 |
Why?
|
| Absorption, Physiological | 1 | 2017 | 2 | 0.140 |
Why?
|
| Tendons | 2 | 2012 | 174 | 0.130 |
Why?
|
| Allografts | 2 | 2015 | 147 | 0.130 |
Why?
|
| Knee | 1 | 2017 | 37 | 0.130 |
Why?
|
| Orthopedic Procedures | 3 | 2019 | 225 | 0.130 |
Why?
|
| Leukocytes | 1 | 2017 | 29 | 0.130 |
Why?
|
| Prosthesis Fitting | 3 | 2011 | 17 | 0.130 |
Why?
|
| Regression Analysis | 1 | 2017 | 215 | 0.130 |
Why?
|
| Registries | 3 | 2022 | 174 | 0.130 |
Why?
|
| Biological Products | 1 | 2017 | 30 | 0.130 |
Why?
|
| Povidone-Iodine | 2 | 2019 | 5 | 0.130 |
Why?
|
| Kidney | 1 | 2017 | 142 | 0.120 |
Why?
|
| Self Concept | 1 | 2016 | 38 | 0.120 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 113 | 0.120 |
Why?
|
| Methicillin | 1 | 2016 | 6 | 0.120 |
Why?
|
| Liposomes | 1 | 2016 | 13 | 0.120 |
Why?
|
| Administration, Intranasal | 1 | 2016 | 26 | 0.120 |
Why?
|
| Methicillin Resistance | 1 | 2016 | 25 | 0.120 |
Why?
|
| Staphylococcal Infections | 2 | 2016 | 155 | 0.120 |
Why?
|
| Nasal Cavity | 1 | 2016 | 31 | 0.120 |
Why?
|
| Injections, Intra-Articular | 1 | 2016 | 56 | 0.120 |
Why?
|
| Sleep Wake Disorders | 1 | 2017 | 110 | 0.120 |
Why?
|
| Prevalence | 3 | 2013 | 380 | 0.120 |
Why?
|
| Staphylococcus aureus | 1 | 2016 | 71 | 0.120 |
Why?
|
| Patella | 2 | 2015 | 53 | 0.120 |
Why?
|
| Chlorhexidine | 1 | 2016 | 62 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 235 | 0.120 |
Why?
|
| Cell Count | 1 | 2015 | 72 | 0.120 |
Why?
|
| Ceramics | 1 | 2015 | 13 | 0.120 |
Why?
|
| Sensitivity and Specificity | 6 | 2015 | 444 | 0.110 |
Why?
|
| Foreign-Body Reaction | 1 | 2015 | 16 | 0.110 |
Why?
|
| Nerve Block | 1 | 2016 | 61 | 0.110 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2018 | 168 | 0.110 |
Why?
|
| Sleep | 1 | 2017 | 270 | 0.110 |
Why?
|
| Intraoperative Complications | 2 | 2013 | 56 | 0.110 |
Why?
|
| Bone Diseases | 2 | 2005 | 19 | 0.110 |
Why?
|
| Length of Stay | 2 | 2013 | 297 | 0.100 |
Why?
|
| Decision Making | 2 | 2006 | 179 | 0.100 |
Why?
|
| Observer Variation | 1 | 2014 | 83 | 0.100 |
Why?
|
| Surveys and Questionnaires | 4 | 2019 | 1036 | 0.100 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2013 | 15 | 0.100 |
Why?
|
| Insurance, Health | 1 | 2013 | 17 | 0.100 |
Why?
|
| Awards and Prizes | 1 | 2013 | 21 | 0.100 |
Why?
|
| Random Allocation | 1 | 2013 | 102 | 0.100 |
Why?
|
| Medicaid | 1 | 2013 | 36 | 0.100 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 67 | 0.100 |
Why?
|
| Bone Remodeling | 1 | 2013 | 48 | 0.100 |
Why?
|
| ROC Curve | 4 | 2016 | 121 | 0.090 |
Why?
|
| Tibial Fractures | 1 | 2012 | 7 | 0.090 |
Why?
|
| Heavy Metal Poisoning | 1 | 2012 | 1 | 0.090 |
Why?
|
| Braces | 1 | 2012 | 20 | 0.090 |
Why?
|
| Reimbursement Mechanisms | 1 | 2012 | 8 | 0.090 |
Why?
|
| Serologic Tests | 1 | 2011 | 8 | 0.090 |
Why?
|
| Predictive Value of Tests | 4 | 2014 | 437 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2012 | 148 | 0.080 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2017 | 251 | 0.080 |
Why?
|
| Suction | 3 | 2015 | 31 | 0.080 |
Why?
|
| Corrosion | 3 | 2015 | 86 | 0.080 |
Why?
|
| Pain Management | 2 | 2022 | 126 | 0.080 |
Why?
|
| Infection Control | 1 | 2011 | 168 | 0.080 |
Why?
|
| Sepsis | 1 | 2010 | 74 | 0.080 |
Why?
|
| Vascular Surgical Procedures | 1 | 2009 | 23 | 0.070 |
Why?
|
| Anesthesia | 1 | 2009 | 28 | 0.070 |
Why?
|
| Ambulatory Care | 1 | 2009 | 66 | 0.070 |
Why?
|
| Preoperative Period | 2 | 2020 | 65 | 0.070 |
Why?
|
| Biomarkers | 3 | 2017 | 481 | 0.070 |
Why?
|
| Hip Fractures | 1 | 2008 | 23 | 0.070 |
Why?
|
| Body Weight | 2 | 2019 | 129 | 0.070 |
Why?
|
| Patient Care Team | 1 | 2009 | 110 | 0.070 |
Why?
|
| Linear Models | 2 | 2018 | 202 | 0.070 |
Why?
|
| Arthritis, Juvenile | 2 | 2017 | 7 | 0.070 |
Why?
|
| Piperidines | 2 | 2017 | 13 | 0.070 |
Why?
|
| Pyrimidines | 2 | 2017 | 24 | 0.070 |
Why?
|
| Arthritis, Psoriatic | 2 | 2017 | 14 | 0.070 |
Why?
|
| Pyrroles | 2 | 2017 | 21 | 0.070 |
Why?
|
| Spondylitis, Ankylosing | 2 | 2017 | 20 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2020 | 377 | 0.060 |
Why?
|
| Chicago | 3 | 2018 | 847 | 0.060 |
Why?
|
| Age Distribution | 2 | 2005 | 69 | 0.060 |
Why?
|
| Sex Distribution | 2 | 2005 | 66 | 0.060 |
Why?
|
| Guided Tissue Regeneration | 1 | 2006 | 8 | 0.060 |
Why?
|
| Joint Dislocations | 2 | 2018 | 50 | 0.060 |
Why?
|
| Surface Properties | 1 | 2006 | 103 | 0.060 |
Why?
|
| Southeastern United States | 1 | 2006 | 14 | 0.060 |
Why?
|
| Neutrophils | 2 | 2017 | 89 | 0.060 |
Why?
|
| Contraindications | 1 | 2006 | 26 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2014 | 804 | 0.060 |
Why?
|
| Ankle Injuries | 1 | 2005 | 8 | 0.060 |
Why?
|
| Salmonella Infections | 1 | 2005 | 1 | 0.060 |
Why?
|
| Osteogenesis | 1 | 2005 | 99 | 0.060 |
Why?
|
| Markov Chains | 1 | 2005 | 30 | 0.060 |
Why?
|
| Animal Husbandry | 1 | 2005 | 6 | 0.060 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2017 | 173 | 0.060 |
Why?
|
| Graft Survival | 1 | 2005 | 84 | 0.060 |
Why?
|
| Swine | 1 | 2005 | 68 | 0.060 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2005 | 97 | 0.050 |
Why?
|
| Databases, Factual | 2 | 2022 | 310 | 0.050 |
Why?
|
| Health Status Indicators | 1 | 2005 | 65 | 0.050 |
Why?
|
| Animals | 3 | 2007 | 3270 | 0.050 |
Why?
|
| Chromium | 2 | 2015 | 56 | 0.050 |
Why?
|
| Cobalt | 2 | 2015 | 71 | 0.050 |
Why?
|
| Tendon Injuries | 1 | 2005 | 154 | 0.050 |
Why?
|
| Young Adult | 3 | 2014 | 1654 | 0.050 |
Why?
|
| Titanium | 2 | 2015 | 139 | 0.050 |
Why?
|
| Hospitalization | 1 | 2005 | 287 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 125 | 0.050 |
Why?
|
| Polyethylenes | 1 | 2002 | 30 | 0.050 |
Why?
|
| Analgesics | 1 | 2022 | 78 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2022 | 106 | 0.040 |
Why?
|
| Comorbidity | 1 | 2003 | 429 | 0.040 |
Why?
|
| Machine Learning | 1 | 2022 | 59 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2003 | 569 | 0.040 |
Why?
|
| Social Class | 1 | 2021 | 57 | 0.040 |
Why?
|
| Statistics, Nonparametric | 2 | 2012 | 106 | 0.040 |
Why?
|
| Recurrence | 2 | 2011 | 268 | 0.040 |
Why?
|
| Benzodiazepines | 1 | 2020 | 45 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2020 | 96 | 0.040 |
Why?
|
| Arthritis | 1 | 2020 | 45 | 0.040 |
Why?
|
| Antidepressive Agents | 1 | 2020 | 89 | 0.040 |
Why?
|
| Pain | 1 | 2022 | 332 | 0.040 |
Why?
|
| Osteoarthritis | 1 | 2003 | 287 | 0.040 |
Why?
|
| Survivorship | 1 | 2019 | 13 | 0.040 |
Why?
|
| Patient Selection | 2 | 2012 | 170 | 0.040 |
Why?
|
| Fracture Fixation, Internal | 1 | 2019 | 57 | 0.040 |
Why?
|
| Child | 1 | 2003 | 1160 | 0.040 |
Why?
|
| Forecasting | 1 | 2018 | 79 | 0.040 |
Why?
|
| Patient Preference | 1 | 2019 | 33 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 171 | 0.030 |
Why?
|
| Adolescent | 1 | 2003 | 1883 | 0.030 |
Why?
|
| Spondylarthritis | 1 | 2017 | 3 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 279 | 0.030 |
Why?
|
| Sex Factors | 2 | 2012 | 399 | 0.030 |
Why?
|
| Cost Savings | 1 | 2017 | 29 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 57 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2017 | 117 | 0.030 |
Why?
|
| Orthopedics | 1 | 2017 | 77 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2015 | 22 | 0.030 |
Why?
|
| Joints | 1 | 2016 | 67 | 0.030 |
Why?
|
| Geography | 2 | 2005 | 15 | 0.030 |
Why?
|
| Patellar Ligament | 1 | 2015 | 35 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2014 | 58 | 0.030 |
Why?
|
| Operative Time | 1 | 2014 | 81 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2014 | 51 | 0.030 |
Why?
|
| Anthropometry | 1 | 2012 | 29 | 0.020 |
Why?
|
| California | 1 | 2012 | 36 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2012 | 16 | 0.020 |
Why?
|
| Fees and Charges | 1 | 2012 | 4 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 594 | 0.020 |
Why?
|
| Causality | 1 | 2011 | 44 | 0.020 |
Why?
|
| Wound Closure Techniques | 1 | 2011 | 5 | 0.020 |
Why?
|
| Arthralgia | 1 | 2012 | 100 | 0.020 |
Why?
|
| Educational Status | 1 | 2012 | 223 | 0.020 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2011 | 26 | 0.020 |
Why?
|
| Acute Disease | 1 | 2011 | 163 | 0.020 |
Why?
|
| Body Size | 1 | 2010 | 6 | 0.020 |
Why?
|
| Age Factors | 1 | 2012 | 650 | 0.020 |
Why?
|
| Analgesia | 1 | 2010 | 34 | 0.020 |
Why?
|
| Prognosis | 1 | 2012 | 730 | 0.020 |
Why?
|
| Accidental Falls | 1 | 2010 | 105 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 871 | 0.020 |
Why?
|
| Intraoperative Care | 1 | 2008 | 39 | 0.020 |
Why?
|
| Fracture Healing | 1 | 2008 | 31 | 0.020 |
Why?
|
| Connective Tissue | 1 | 2007 | 19 | 0.020 |
Why?
|
| Materials Testing | 1 | 2007 | 101 | 0.020 |
Why?
|
| Research | 1 | 2006 | 36 | 0.020 |
Why?
|
| Equipment Design | 1 | 2006 | 119 | 0.010 |
Why?
|
| Walking | 1 | 2008 | 234 | 0.010 |
Why?
|
| Medicare Part B | 1 | 2005 | 1 | 0.010 |
Why?
|
| Health Services for the Aged | 1 | 2005 | 6 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 192 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2008 | 1103 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2003 | 96 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 320 | 0.010 |
Why?
|